GlassScriptPhysician profile
Katie R Edwards
NPI 1811650609
$1,146.24
in general payments reported to CMS, 2019-2025
17 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $476 · 2024: $239 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $987 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.24 |
| Education | $159.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $279.30 | 2023-2025 | Erleada, Akeega |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.88 | 2025 | Relistor |
| Astellas Pharma US INC | $159.00 | 2023 | |
| Sumitomo Pharma America, INC. | $96.61 | 2023-2024 | Orgovyx |
| Boston Scientific Corporation | $76.56 | 2024 | Ams 700 |
| Procept Biorobotics Corporation | $49.28 | 2024 | Aquabeam System |
| Takeda Pharmaceuticals U.S.A., INC. | $48.26 | 2025 | Hyqvia |
| Novartis Pharmaceuticals Corporation | $36.28 | 2024 | |
| Grifols USA, LLC | $29.09 | 2025 | Gamunex-C |
| Acadia Pharmaceuticals INC | $25.48 | 2025 | Nuplazid |
| Emd Serono, INC. | $21.51 | 2025 | |
| Averitas Pharma INC. | $21.36 | 2025 | Qutenza |
| Teleflex LLC | $20.15 | 2024 | |
| Progenics Pharmaceuticals, INC. | $19.66 | 2024 | |
| Ucb, INC. | $17.47 | 2025 | Zilbrysq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $16.46 | 2025 | Austedo Xr |
| Tonix Medicines, INC. | $13.89 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.